EverPoint Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

EverPoint Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.29M	Buy	110,000 +10,000	+10%	+$260K	0.04%	316
2016 Q3	$3.28M	Sell	100,000 -250,000	-71%	-$7.61M	0.06%	296
2016 Q2	$8.74M	Sell	350,000 -425,000	-55%	-$11.5M	0.17%	162
2016 Q1	$19M	Buy	775,000 +175,000	+29%	+$4.05M	0.37%	62
2015 Q4	$19.8M	Buy	600,000 +230,000	+62%	+$7.78M	0.42%	60
2015 Q3	$12.1M	Buy	+370,000	New	+$15.7M	0.31%	86
2015 Q1	–	Sell	-83,527	Closed	-$2.43M	–	632
2014 Q4	$2.43M	Buy	+83,527	New	+$1.5M	0.05%	348

Other funds holding ALDR

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return